ADENOSINE
OTHER BRAND NAMES
Adenocard
Adenoscan
Adeno-jec
My-O-den
Adenocor
THERAPEUTIC
CLASSIFICATION
Class V antiarrhythmic agent
Adenosine also plays a role in
regulation of blood flow to various
organs through vasodilation
AVAILABILITY
Adenosine 3mg/ml .
Each vial contains 6mg = 2ml
A clear, colourless solution free
from visible particles
THERAPEUTIC INDICATIONS
Adenoscan is a coronary
vasodilator.
ADENOSINE INDICATION
Therapeutic: Rapid conversion to a normal
sinus rhythm of paroxysmal supraventricular
tachycardia (SVT).
DRUG ACTION
Antiarrhythmic actions:
Slows impulse formation of the sino-atrial node
Slows conduction time through the atrio-ventricular
node
Can interrupt re-entry pathways through the
atrioventricular node
Coronary vasodilator
Respiratory stimulant- increase ventilation and
decrease PCO2
INTERRUPT RE-ENTRY PATHWAYS
CONTRAINDICATIONS
Hypersensitivity to adenosine
Second or third degree heart block
(unless a functioning artificial
pacemaker present)
Sinus node dysfunction, such as sick
sinus syndrome or symptomatic
bradycardia (unless a functioning
artificial pacemaker present)
CONTRAINDICATIONS
Bronchoconstriction or
bronchospastic lung disease (e.g.
asthma) either known or suspected.
Severe hypotension.
ADVERSE EFFECTS
Adverse effects resolve rapidly due to the drugs
short duration of action
Common: flushing, dyspnoea, chest
pain/pressure, nausea or abdominal discomfort,
headache, dizziness, apprehension, burning
sensation, bradycardia, asystole, sinus pause &
A-V block
Infrequent: transient arrhythmias, recurrence
of SVT, hypotension, tingling in arms or legs,
metallic taste
Rare: bronchospasm, injection site reaction
DRUG INTERACTION
Methylxanthines (eg, caffeine, theophylline) are
adenosine receptor antagonists and inhibit adenosines
vasoactive effects; withhold methylxanthines before
adenosine administration
Aminophylline may increase risk of seizures associated
with adenosine.
The dose is often decreased in patients on dipyridamole
(Persantine) and diazepam (Valium) because adenosine
potentiates the effects of these drugs.
STORAGE
Store at controlled room
temperature of 15-30C
Do not refrigerate; possible crystal
formation
Solution must be clear prior to
administration
Any unused portion should be
discarded.
ADMINISTRATION INSTRUCTIONS
Universal precautions
Administer adenosine undiluted by rapid IV bolus
(over 2 seconds) followed by a rapid 20 mL sodium
chloride 0.9% flush.
Adenosine has a very short duration of effect
making it necessary to give as a rapid bolus
Warn patient they may experience anxiety or a
feeling of impending doom - this will pass
quickly.
Administer either directly into a large peripheral
vein or into an IV line.
Patients who develop high level AV block at a
particular dose should not be given further dosage
increments.
NURSING IMPLICATION
Monitor heart rate frequently (every 15 30 sec) and
ECG continuously during therapy. A short,
transient period of 1st-, 2nd-, or 3rd-degree heart
block or asystole may occur following injection;
usually resolves quickly due to short duration of
adenosine.
Once conversion to normal sinus rhythm is
achieved, transient arrhythmias (premature
ventricular contractions, atrial premature
contractions, sinus tachycardia, sinus bradycardia,
skipped beats, AV nodal block) may occur, but
generally last a few seconds.
Monitor BP during therapy.
Assess respiratory status (breath sounds, rate)
following administration. Patients with history of
asthma may experience bronchospasm.
Done